Sixty-five common genetic variants and prediction of type 2 diabetes

Diabetes

Volumn 64, Issue 5, 2015, Pages 1830-1840

  Talmud, Philippa J ^a   Cooper, Jackie A ^a   Morris, Richard W ^a   Dudbridge, Frank ^b   Shah, Tina ^a   Engmann, Jorgen ^a   Dale, Caroline ^b   White, Jon ^a   Mclachlan, Stela ^c   Zabaneh, Delilah ^a   Wong, Andrew ^a   Ong, Ken K ^a,d   Gaunt, Tom ^e   Holmes, Michael V ^a,f   Lawlor, Debbie A ^e   Richards, Marcus ^a   Hardy, Rebecca ^a   Kuh, Diana ^a   Wareham, Nicholas ^d   Langenberg, Claudia ^a,d   Ben Shlomo, Yoav ^e   Wannamethee, S Goya ^a   Strachan, Mark W J ^g   Kumari, Meena ^a   Whittaker, John C ^h   Drenos, Fotios ^a,e   Kivimaki, Mika ^a   Hingorani, Aroon D ^a   Price, Jacqueline F ^c   Humphries, Steve E ^a   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g WESTERN GENERAL HOSPITAL   (United Kingdom)

^h GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CALIBRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GENDER; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGING; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; ODDS RATIO; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEX FACTORS;

EID: 84981551346     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1504     Document Type: Article

References (25)

1. Færch K, Witte DR, Tabák AG, et al. Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: A post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes Endocrinol 2013;1:43-51.
2. Sinharoy K, Mandal L, Chakrabarti S, Paul UK, Bandyopadhyay R, Basu AK. A study on clinical and biochemical profile of low body weight type 2 diabetes mellitus. J Indian Med Assoc 2008;106:747-750.
3. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ 2011;343:7163.
4. Lyssenko V, Laakso M. Genetic screening for the risk of type 2 diabetes: Worthless or valuable? Diabetes Care 2013;36(Suppl. 2):S120-S126.
5. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr. Prediction of incident diabetes mellitus in middle- Aged adults: The Framingham Offspring Study. Arch Intern Med 2007;167:1068-1074.
6. Talmud PJ, Hingorani AD, Cooper JA, et al. Utility of genetic and nongenetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 2010;340:b4838.
7. Saxena R, Elbers CC, Guo Y, et al.; Look AHEAD Research Group; DIAGRAM consortium. Large-scale gene-centric meta- Analysis across 39 studies identifies type 2 diabetes loci [published correction appears in Am J Hum Genet 2012;90: 753]. Am J Hum Genet 2012;90:410-425.
8. Morris AP, Voight BF, Teslovich TM, et al.; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta- Analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012;44:981-990.
9. de Miguel-Yanes JM, Shrader P, Pencina MJ, et al.; MAGIC Investigators; DIAGRAM+ Investigators. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 2011;34:121-125.
10. Walford GA, Porneala BC, Dauriz M, et al. Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Diabetes Care 2014;37:2508-2514.
11. Vassy JL, Hivert MF, Porneala B, et al. Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 2014;63:2172-2182.
12. Langenberg C, Sharp SJ, Franks PW, et al. Gene-lifestyle interaction and type 2 diabetes: The EPIC interact case-cohort study. PLoS Med 2014;11:e1001647.
13. Almgren P, Lehtovirta M, Isomaa B, et al.; Botnia Study Group. Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 2011;54:2811-2819.
14. Shah T, Engmann J, Dale C, et al.; UCLEB Consortium. Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium [published correction appears in PLoS One 2014;8]. PLoS ONE 2013;8:e71345.
15. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c- Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478.
16. Voight BF, Kang HM, Ding J, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 2012;8:e1002793.
17. Sanghera DK, Blackett PR. Type 2 Diabetes Genetics: Beyond GWAS. J Diabetes Metab 2012;3:6948-6963.
18. Pencina MJ, D'Agostino RB Sr, Demler OV. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med 2012; 31:101-113.
19. Ganna A, Reilly M, de Faire U, Pedersen N, Magnusson P, Ingelsson E. Risk prediction measures for case-cohort and nested case-control designs: An application to cardiovascular disease. Am J Epidemiol 2012;175:715-724.
20. Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ. A simple risk score identifies individuals at high risk of developing Type 2 diabetes: A prospective cohort study. Fam Pract 2008;25:191-196.
21. Hivert MF, Vassy JL, Meigs JB. Susceptibility to type 2 diabetes mellitus- from genes to prevention. Nat Rev Endocrinol 2014;10:198-205.
22. Lohmueller KE, Sparsø T, Li Q, et al. Whole-exome sequencing of 2, 000 Danish individuals and the role of rare coding variants in type 2 diabetes. Am J Hum Genet 2013;93:1072-1086.
23. Tanaka D, Nagashima K, Sasaki M, et al. Exome sequencing identifies a new candidate mutation for susceptibility to diabetes in a family with highly aggregated type 2 diabetes. Mol Genet Metab 2013;109:112-117.
24. Pennells L, Kaptoge S, White IR, Thompson SG, Wood AM; Emerging Risk Factors Collaboration. Assessing risk prediction models using individual participant data from multiple studies. Am J Epidemiol 2014;179:621-632.
25. Grant RW, O'Brien KE, Waxler JL, et al. Personalized genetic risk counseling to motivate diabetes prevention: A randomized trial. Diabetes Care 2013; 36:13-19.